TP53 and neoplasm: Overexpression of Mycl, a transcription factor member of a family of oncogenes which was found amplified in ~9% of human SCLC [17] together with the targeted deletion of Rb1 and Trp53 showed an earlier onset of SCLC and shortened latency of tumor development.